[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628451":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":26,"responsibleParty":68,"collaborators":70,"id":77,"slug":78,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":79,"sex":85,"minAge":86,"maxAge":10,"enrollmentInfo":87,"targetDuration":90,"studyType":91,"phases":10,"briefSummary":92,"conditions":93,"keywords":95,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"People with type 1 diabetes mellitus",null,"Individuals with type 1 diabetes mellitus (T1D) cared for at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau.",[13],{"name":14,"affiliation":5,"role":15},"Rosa M Corcoy","PRINCIPAL_INVESTIGATOR",[17,23],{"name":18,"role":19,"phone":20,"phoneExt":21,"email":22},"Eva Safont, MD","CONTACT","+34686203964","5661","esafont@santpau.cat",{"name":24,"role":19,"phone":20,"phoneExt":21,"email":25},"Rosa M Corcoy, MD, PhD","rcorcoy@santpau.cat",[27],{"facility":28,"status":29,"city":30,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona 08041","RECRUITING","Barcelona","08025","Spain","ES",{"type":35,"coordinates":36},"Point",[37,38],2.15899,41.38879,{"lat":38,"lon":37},[41,44,45,46,48,50,52,54,56,58,60,62,64,66],{"name":42,"role":19,"phone":43,"phoneExt":10,"email":25},"Rosa Corcoy, MD PhD","+34 935565661",{"name":18,"role":19,"phone":43,"phoneExt":10,"email":22},{"name":42,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":18,"role":47,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":49,"role":47,"phone":10,"phoneExt":10,"email":10},"Ana Chico, MD PhD",{"name":51,"role":47,"phone":10,"phoneExt":10,"email":10},"Alex Mesa, MD PhD",{"name":53,"role":47,"phone":10,"phoneExt":10,"email":10},"Helena Sardà, MD",{"name":55,"role":47,"phone":10,"phoneExt":10,"email":10},"Lilian C Mendoza, MD PhD",{"name":57,"role":47,"phone":10,"phoneExt":10,"email":10},"Natalia Mangas, RN",{"name":59,"role":47,"phone":10,"phoneExt":10,"email":10},"Dídac Mauricio, MD PhD",{"name":61,"role":47,"phone":10,"phoneExt":10,"email":10},"Santiago Martinez, MD",{"name":63,"role":47,"phone":10,"phoneExt":10,"email":10},"Jose M Cubero, MD PhD",{"name":65,"role":47,"phone":10,"phoneExt":10,"email":10},"Romina Miranda, PhD",{"name":67,"role":47,"phone":10,"phoneExt":10,"email":10},"Bogdan Vlacho, PhD",{"type":69,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[71,74],{"name":72,"class":73},"Sociedad Española de Diabetes","NETWORK",{"name":75,"class":76},"Associació Catalana de Diabetis","UNKNOWN","100628451","characterization-of-type-1-diabetes-subgroup-an-artificial-intelligence-analysis-of-clinical-and-glucometric-features-100628451",false,"NCT07461805","Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features","Caracterización de Subgrupos de Personas Con Diabetes Tipo 1: análisis de características clínicas y glucométricas Utilizando Una aproximación de Inteligencia Artificial","T1DC","Inclusion Criteria:\n\n* Individuals with type 1 diabetes (T1D) aged 18 years or older.\n* T1D individuals expected to have regular follow-up at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau.\n* Users of continuous glucose monitoring (CGM) systems for at least the last 6 months of 2024.\n* Willingness and ability to provide written informed consent to participate in the study (by the patient or his\u002Fher representative).\n\nExclusion Criteria:\n\n* Presence of severe comorbidities or medical conditions that, in the investigator's judgment, could interfere with participation in the study or the interpretation of results. This circumstance is expected to be exceptional, as the study aims to be as inclusive as possible.","ALL","18 Years",{"count":88,"type":89},800,"ESTIMATED","4 Years","OBSERVATIONAL","The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is:\n\nAre there distinct subtypes among people with type 1 diabetes?\n\nParticipants will be invited to take part in the study by allowing access to their health data. They will not be required to undergo any additional examinations, tests, visits, or interventions.",[94],"Type 1 Diabetes Mellitus",[96,97,98,99],"Artificial intelligence","glucometry","Clusters","Type 1 diabetes mellitus","2026-03-06",{"date":102,"type":103},"2026-03-10","ACTUAL",{"date":105,"type":103},"2025-11-04",{"date":107,"type":89},"2028-12",{"name":5,"class":6},1]